| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 10 |
| 1 | BACLOFEN INJECTION | 8 |
| 2 | MACITENTAN | 6 |
| 3 | SILDENAFIL CITRATE | 6 |
| 4 | TADALAFIL | 6 |
| 5 | ECULIZUMAB | 5 |
| 6 | EPOPROSTENOL | 5 |
| 7 | AMBRISENTAN | 4 |
| 8 | RIOCIGUAT | 4 |
| 9 | SODIUM CHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BACLOFEN INJECTION | 8 | 0.0026 |
| 1 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 1 | 0.0025 |
| 2 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| 3 | CERLIPONASE ALFA | 1 | 0.0019 |
| 4 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 1 | 0.0015 |
| 5 | ETEPLIRSEN | 3 | 0.0012 |
| 6 | CASIMERSEN | 1 | 0.0010 |
| 7 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 8 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 9 | ELOSULFASE ALFA | 3 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Antisense Oligonucleotide [EPC] | 4 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 4 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 4 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |
| 6 | Prostacycline Vasodilator [EPC] | 15 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 6 | 0.0001 |
| 8 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 9 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |